Foresight Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Foresight Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $446,851 - $523,429	-7,552 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$57.74 - $65.43 $10,450 - $11,842	-181 Reduced 2.34%	7,552 $468,000
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $57 - $63	1 Added 0.01%	7,733 $466,000
Q2 2020 Jul 15, 2020	SELL	$54.82 - $64.09 $430,172 - $502,914	-7,847 Reduced 50.37%	7,732 $455,000
Q1 2020 Apr 15, 2020	SELL	$46.4 - $67.43 $38,790 - $56,371	-836 Reduced 5.09%	15,579 $868,000

Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $50,981 - $66,500	-1,036 Reduced 5.94%	16,415 $1.05 Million
Q3 2019 Oct 25, 2019	BUY	$42.77 - $50.71 $42 - $50	1 Added 0.01%	17,451 $885,000
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $850,862 - $1.1 Million	17,450 New	17,450 $907,000

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85.2B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Foresight Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresight Wealth Management, LLC with notifications on news.